SNCA and Parkinson disease: Although the biological mechanism of abnormal iron metabolism in patients with Parkinson’s disease is not clear, it is certain that the disease is closely related to the imbalance of iron absorption, storage and release in vivo, which is likely to be the main factor leading to the loss of dopamine neurons and abnormal aggregation of α-synuclein [4].